SCHEMBL17660286

SCHEMBL17660286

CC(C)CN1CCc2cc(C(C)(C)C)ccc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 9/20 0.43
▸ KCNH2 Q12809 3/20 0.41
▸ GRM5 P41594 4/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ PLA2G1B P04054 1/20 0.39
▸ NFKB1 P19838 1/20 0.39
▸ CASP3 P42574 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ NFKB2 Q00653 1/20 0.39
▸ RELA Q04206 1/20 0.39
▸ SENP8 Q96LD8 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.39
▸ BTK Q06187 1/20 0.39
▸ PER2 O15055 1/20 0.38
▸ CRY2 Q49AN0 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17663695 0.85 HRH3 (0.45) HRH3KCNH2GRM5BTK
SCHEMBL24934195 0.81 PRMT5 (0.53) HRH3KCNH2GRM5NFKB1CYP3A4
SCHEMBL30162812 0.81 PRMT5 (0.53) HRH3KCNH2GRM5NFKB1CYP3A4
SCHEMBL12870533 0.80 PRMT5 (0.48) HRH3KCNH2GRM5PRMT5WDR77
SCHEMBL17645644 0.77 GRM5 (0.48) HRH3KCNH2GRM5ALDH1A1BTK
SCHEMBL13622582 0.77 PER2 (0.51) NPC1ALDH1A1RAB9APER2CRY2
SCHEMBL16456038 0.77 GRM5 (0.54) HRH3GRM5NPC1ALDH1A1PLA2G1B
SCHEMBL16456020 0.76 ALDH1A1 (0.40) HRH3KCNH2GRM5NPC1ALDH1A1
SCHEMBL20365222 0.73 KCNH2 (0.53) HRH3KCNH2GRM5BTK
SCHEMBL17646052 0.73 BTK (0.52) HRH3KCNH2GRM5BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190233417-A1 HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2019-08-01 — — US disclosed
US-10253023-B2 Heteroaryl compounds as BTK inhibitors and uses thereof MERCK PATENT GMBH (DE) 2019-04-09 — — US disclosed
US-20160096834-A1 HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF MERCK PATENT GMBH (DE) 2016-04-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10253023-B2 Heteroaryl compounds as BTK inhibitors and uses thereof BTK, SYK, LYN HRH3 1230/4885KCNH2 2866/4885GRM5 4105/4885
US-20190233417-A1 HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF BTK, SYK, LYN HRH3 1177/4885KCNH2 3016/4885GRM5 4303/4885
US-20160096834-A1 HETEROARYL COMPOUNDS AS BTK INHIBITORS AND USES THEREOF BTK, SYK, LYN HRH3 1230/4885KCNH2 2866/4885GRM5 4105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback